Molnupiravir for treating COVID-19 [ID6340]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Remdesivir and tixagevimab plus cilgavimab for treating COVID-19 [ID6261]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Sipavibart for preventing COVID-19 [ID6282]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC